Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021184

Expand all

AVAGE (TAZAROTENE)
0.1%
Marketing Status: Prescription
Active Ingredient: TAZAROTENE
Proprietary Name: AVAGE
Dosage Form; Route of Administration: CREAM; TOPICAL
Strength: 0.1%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021184
Product Number: 003
Approval Date: Sep 30, 2002
Applicant Holder Full Name: ALLERGAN INC
Marketing Status:  Prescription
Patent and Exclusivity Information
TAZORAC (TAZAROTENE)
0.05%
Marketing Status: Prescription
Active Ingredient: TAZAROTENE
Proprietary Name: TAZORAC
Dosage Form; Route of Administration: CREAM; TOPICAL
Strength: 0.05%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021184
Product Number: 001
Approval Date: Sep 29, 2000
Applicant Holder Full Name: ALLERGAN INC
Marketing Status:  Prescription
Patent and Exclusivity Information
TAZORAC (TAZAROTENE)
0.1%
Marketing Status: Prescription
Active Ingredient: TAZAROTENE
Proprietary Name: TAZORAC
Dosage Form; Route of Administration: CREAM; TOPICAL
Strength: 0.1%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021184
Product Number: 002
Approval Date: Sep 29, 2000
Applicant Holder Full Name: ALLERGAN INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English